Open AccessLong-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
Author(s) -
Styrbjörn Friman,
Giuseppe Tisone,
Frederik Nevens,
Frank Lehner,
W. Santaniello,
Wolf O. Bechstein,
Sergey V. Zhuvarel,
Helena Isoniemi,
О. О. Руммо,
Jürgen Klempnauer,
Swapneel Anaokar,
Martin D. Hurst,
Gbenga Kazeem,
Nasrullah Undre,
Pavel Trunečka
Publication year - 2021
Publication title -
transplantation direct
Language(s) - English
Resource type - Journals
ISSN - 2373-8731
DOI - 10.1097/txd.0000000000001166
Subject(s) - medicine , basiliximab , calcineurin , immunosuppression , tacrolimus , liver transplantation , regimen , clinical endpoint , urology , gastroenterology , mycophenolic acid , transplantation , surgery , randomized controlled trial